Cargando…
Flecainide is a safe and effective treatment for pre-excited atrial fibrillation rapidly conducted to the ventricle in pregnant women: a case series
BACKGROUND: Pregnancy is associated with an increased incidence of cardiac arrhythmias likely due to hormonal, haemodynamic, and autonomic changes. Yet, there is little data available regarding the efficacy and safety of anti-arrhythmic agents to prevent pre-excited atrial fibrillation (AF) in pregn...
Autores principales: | Chauveau, Samuel, Le Vavasseur, Olivier, Morel, Elodie, Dulac, Arnaud, Chevalier, Philippe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6601159/ https://www.ncbi.nlm.nih.gov/pubmed/31449645 http://dx.doi.org/10.1093/ehjcr/ytz066 |
Ejemplares similares
-
Delayed diagnosis of Brugada syndrome in a patient with aborted sudden cardiac death and initial negative flecainide challenge
por: Chauveau, Samuel, et al.
Publicado: (2017) -
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation
por: Aliot, Etienne, et al.
Publicado: (2011) -
Additional coronary sinus shocking lead as rescue therapy after multiple internal and external defibrillation failures
por: Chauveau, Samuel, et al.
Publicado: (2017) -
Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation
por: Gjermeni, Erind, et al.
Publicado: (2019) -
Acute atrial wall stretch and the efficacy of flecainide-induced conversion of atrial fibrillation
por: van Hemel, N.M., et al.
Publicado: (2015)